ロード中...
The renin-angiotensin system and specifically angiotensin-converting enzyme 2 as a potential therapeutic target in SARS-CoV-2 infections
In March 2019, the global COVID-19 pandemic caused by the novel SARS-CoV-2 coronavirus began. The first cases of SARS-CoV-2 infection occurred in November 19 in Wuhan, China. Preventive measures taken have not prevented the rapid spread of the virus to countries around the world. To date, there are...
保存先:
| 出版年: | Naunyn Schmiedebergs Arch Pharmacol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Berlin Heidelberg
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8214977/ https://ncbi.nlm.nih.gov/pubmed/34151392 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00210-021-02108-z |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|